Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
12/03/2008 | CN100438864C Eye medicine for treating fungal keratitis |
12/03/2008 | CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient |
12/03/2008 | CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
12/02/2008 | US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver |
12/02/2008 | US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism |
12/02/2008 | US7459455 Pyrimidine compounds |
12/02/2008 | US7459441 Remedies for dry eye and diseases associated with dry eye |
12/02/2008 | US7459440 Ocular tear growth factor-like protein |
12/02/2008 | US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery |
12/02/2008 | CA2361841C Mevinolin derivatives |
12/02/2008 | CA2346631C Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media |
12/02/2008 | CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
12/02/2008 | CA2306371C Use of flunarizine for the topical treatment of glaucoma |
12/02/2008 | CA2305548C Prostaglandin agonists and their use to treat bone disorders |
11/27/2008 | WO2008144623A1 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure |
11/27/2008 | WO2008144399A1 COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS |
11/27/2008 | WO2008144347A1 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections |
11/27/2008 | WO2008143254A1 Pharmaceutical containing pparδ agonist |
11/27/2008 | WO2008096804A8 Eye drop preparation comprising latanoprost |
11/27/2008 | WO2008080037A3 Carotenoids of enhanced bioavailability |
11/27/2008 | US20080293791 Valsartan salts |
11/27/2008 | US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors |
11/27/2008 | US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases |
11/27/2008 | US20080292726 Ophthalmic gallium compositions and methods of their use |
11/27/2008 | US20080292680 Hypercompressed polymer particles for controlled release ophthalmic medications |
11/27/2008 | US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae |
11/27/2008 | US20080292614 DNA sequences for human angiogenesis genes |
11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
11/27/2008 | CA2687957A1 Pharmaceutical containing ppar.delta. agonist |
11/27/2008 | CA2686720A1 Drug delivery system with scleral lens |
11/26/2008 | EP1995243A1 Triazole derivative or salt thereof |
11/26/2008 | EP1994933A1 Aqueous composition |
11/26/2008 | EP1994932A1 Use of N-desmethylclozapine to treat human psychosis |
11/26/2008 | EP1994931A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
11/26/2008 | EP1994929A1 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases |
11/26/2008 | EP1993673A2 Injectable combination therapy for eye disorders |
11/26/2008 | EP1993619A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
11/26/2008 | EP1993584A2 Compositions and methods for the treatment of ophthalmic disease |
11/26/2008 | EP1993578A1 Substance for the treatment of tinnitus |
11/26/2008 | EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
11/26/2008 | EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
11/26/2008 | EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
11/26/2008 | EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
11/26/2008 | EP1381382B1 Methods and compositions for the treatment of diseases of the eye |
11/26/2008 | EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases |
11/26/2008 | EP1234574B1 Hair growth stimulant |
11/26/2008 | CN101312962A Therapeutic agent for cornea/conjunctive disorder |
11/26/2008 | CN101310771A Visual function disorder improving agents |
11/26/2008 | CN100436439C Dimeric isoflavones |
11/25/2008 | US7456253 Growth hormone releasing peptides |
11/25/2008 | US7456158 4-dedimethylaminotetracycline derivatives |
11/25/2008 | US7455986 Heparinase III and methods of specifically cleaving therewith |
11/25/2008 | US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance |
11/25/2008 | US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule |
11/25/2008 | CA2433032C Sustained release drug delivery devices with coated drug cores |
11/25/2008 | CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
11/20/2008 | WO2008140052A1 Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient |
11/20/2008 | WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
11/20/2008 | WO2008139845A1 Novel amide derivative |
11/20/2008 | WO2008139574A1 Crystalline form of lactam compound and process for producing the same |
11/20/2008 | WO2008138350A1 Prevention of intraocular fibrosis |
11/20/2008 | WO2008101052A8 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
11/20/2008 | WO2008094912B1 Substituted gamma lactams as therapeutic agents |
11/20/2008 | WO2008006052A3 Bicyclic heteroaryl inhibitors of pde4 |
11/20/2008 | US20080287528 Therapeutic methods and compositions involving isoflavones |
11/20/2008 | US20080287501 Therapeutic uses of an insulin secretion enhancer |
11/20/2008 | US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
11/20/2008 | US20080287489 Ophthalmic compositions for treating ocular hypertension |
11/20/2008 | US20080287477 Novel Compounds as Modulators of Ppar |
11/20/2008 | US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene |
11/20/2008 | US20080287381 Injectable Agent for the Targeted Treatment of Retinal Ganglion Cells |
11/20/2008 | US20080287341 Treatment of vascular abnormalities using nanoparticles |
11/20/2008 | US20080286378 Administering via eye drops |
11/20/2008 | US20080286338 Drug delivery system with scleral lens |
11/20/2008 | US20080286337 Method of treating a disease in an eye using a scleral lens |
11/20/2008 | US20080286334 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration |
11/20/2008 | US20080286303 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media |
11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
11/20/2008 | US20080286255 Treatment for eye disorder |
11/20/2008 | US20080286250 Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf |
11/20/2008 | US20080286211 Treating pain associated with epithelial lesions and disorders of impaired mucin function using a pharmaceutical composition containing mucin glycoproteins in combination with therapeutic agents, e.g., trefoil polypeptides |
11/20/2008 | CA2686394A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
11/19/2008 | EP1992644A1 Antibodies against CCR4 and its fragments |
11/19/2008 | EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth |
11/19/2008 | EP1992340A1 Improved ophthalmic and contact lens solution |
11/19/2008 | EP1992317A2 Devices for intraocular drug delivery |
11/19/2008 | EP1991249A2 Treatment with cyclosporin a |
11/19/2008 | EP1991218A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
11/19/2008 | EP1991205A1 Ocular therapy using sirtuin-activating agents |
11/19/2008 | EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS |
11/19/2008 | EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
11/19/2008 | EP1453539B1 Immunotherapeutic methods and systems |
11/19/2008 | EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
11/19/2008 | CN101309923A N-sulfamoyl-N -benzopyranpiperidines as inhibitors of carbonic anhydrases |
11/19/2008 | CN101309667A Medical composite treating disease of inner ear |
11/19/2008 | CN101307017A Amino-methyl substituted tetracycline compounds |
11/19/2008 | CN101306144A Decoction for treating otitis media suppurativa acuta |
11/19/2008 | CN101306143A Ear drops for treating otitis media suppurativa acuta |